Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus

Bone Marrow Transplantation

Volumn 28, Issue 7, 2001, Pages 713-715

  Takahata, M ^a   Hashino, S ^a   Izumiyama, K ^a   Chiba, K ^a   Suzuki, S ^a   Asaka, M ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bone marrow transplantation; Cyclosporin A; Encephalopathy; Tacrolimus

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CEFTAZIDIME; CHOLESTEROL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; LYMPHOGLOBULINE; MAGNESIUM; METHOTREXATE; OSMOTIC DIURETIC AGENT; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANAMNESIS; APLASTIC ANEMIA; ARTICLE; BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; BRAIN DISEASE; CASE REPORT; CONVULSION; DISEASE SEVERITY; DONOR; DRUG BLOOD LEVEL; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG MONITORING; FEMALE; GRAFT VERSUS HOST REACTION; HEADACHE; HEPATITIS B; HLA MATCHING; HUMAN; LONG TERM CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT DISEASE; SIBLING; WHOLE BODY RADIATION;

ADULT; ANEMIA, APLASTIC; ANTICONVULSANTS; BLOOD-BRAIN BARRIER; BONE MARROW TRANSPLANTATION; BRAIN DISEASES; BRAIN EDEMA; CEFTAZIDIME; CEREBRAL HEMORRHAGE; CYCLOSPORINE; DIAGNOSIS, DIFFERENTIAL; DIURETICS; ENDOTHELIUM, VASCULAR; EPILEPSY, GENERALIZED; FEMALE; FLUCONAZOLE; GRAFT VS HOST DISEASE; HEADACHE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRACRANIAL HYPERTENSION; MAGNETIC RESONANCE IMAGING; TACROLIMUS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034748126     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703221     Document Type: Article

References (8)

1. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy
2. Cyclosporin A neurotoxicity after allogeneic bone marrow transplantation
3. Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells
4. Central nervous system toxicity after liver transplantation
5. Association between cyclosporin neurotoxicity and hypomagnesaemia
6. Cyclosporine-related encephalopathy following allogeneic bone marrow transplantation
7. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporine
8. Cyclosporine neurotoxicity: A review